OBJECTIVE: To determine the impact of 2 probiotic bifidobacteria on the fecal microbiota of premature infants fed either human milk or formula. STUDY DESIGN: In the first of two phase 1 clinical trials, 12 premature infants receiving formula feedings were assigned randomly to receive either Bifidobacterium longum ssp infantis or Bifidobacterium animalis ssp lactis in increasing doses during a 5-week period. In the second, 9 premature infants receiving their mother's milk received each of the two bifidobacteria for 2 weeks separated by a 1-week washout period. Serial stool specimens from each infant were analyzed by terminal restriction fragment-length polymorphism and quantitative polymerase chain reaction for bacterial composition. RESULTS: Among the formula-fed infants, there was a greater increase in fecal bifidobacteria among infants receiving B infantis (Binf) than those receiving B lactis (Blac). This difference was most marked at a dose of 1.4 × 10(9) colony-forming units twice daily (P < .05). Bacterial diversity improved over dose/time in those infants receiving Binf. Among the human milk-fed infants, greater increases in fecal bifidobacteria and decreases in γ-Proteobacteria followed the administration of Binf than Blac. The B longum group (which includes Binf but not Blac) was the dominant bifidobacteria among the human milk-fed infants, regardless of the probiotic administered. CONCLUSIONS: Binf was more effective at colonizing the fecal microbiota than Blac in both formula-fed and human milk-fed premature infants. The combination of human milk plus Binf resulted in the greatest fecal levels of bifidobacteria.
RCT Entities:
OBJECTIVE: To determine the impact of 2 probiotic bifidobacteria on the fecal microbiota of premature infants fed either human milk or formula. STUDY DESIGN: In the first of two phase 1 clinical trials, 12 premature infants receiving formula feedings were assigned randomly to receive either Bifidobacterium longum ssp infantis or Bifidobacterium animalis ssp lactis in increasing doses during a 5-week period. In the second, 9 premature infants receiving their mother's milk received each of the two bifidobacteria for 2 weeks separated by a 1-week washout period. Serial stool specimens from each infant were analyzed by terminal restriction fragment-length polymorphism and quantitative polymerase chain reaction for bacterial composition. RESULTS: Among the formula-fed infants, there was a greater increase in fecal bifidobacteria among infants receiving B infantis (Binf) than those receiving B lactis (Blac). This difference was most marked at a dose of 1.4 × 10(9) colony-forming units twice daily (P < .05). Bacterial diversity improved over dose/time in those infants receiving Binf. Among the human milk-fed infants, greater increases in fecal bifidobacteria and decreases in γ-Proteobacteria followed the administration of Binf than Blac. The B longum group (which includes Binf but not Blac) was the dominant bifidobacteria among the human milk-fed infants, regardless of the probiotic administered. CONCLUSIONS: Binf was more effective at colonizing the fecal microbiota than Blac in both formula-fed and human milk-fed premature infants. The combination of human milk plus Binf resulted in the greatest fecal levels of bifidobacteria.
Authors: Zaid Abdo; Ursel M E Schüette; Stephen J Bent; Christopher J Williams; Larry J Forney; Paul Joyce Journal: Environ Microbiol Date: 2006-05 Impact factor: 5.491
Authors: Elisabeth A M Westerbeek; Anemone van den Berg; Harrie N Lafeber; Jan Knol; Willem P F Fetter; Ruurd M van Elburg Journal: Clin Nutr Date: 2006-05-04 Impact factor: 7.324
Authors: C N Larsen; S Nielsen; P Kaestel; E Brockmann; M Bennedsen; H R Christensen; D C Eskesen; B L Jacobsen; K F Michaelsen Journal: Eur J Clin Nutr Date: 2006-05-24 Impact factor: 4.016
Authors: Robert E Ward; Milady Niñonuevo; David A Mills; Carlito B Lebrilla; J Bruce German Journal: Mol Nutr Food Res Date: 2007-11 Impact factor: 5.914
Authors: J R Cole; B Chai; R J Farris; Q Wang; A S Kulam-Syed-Mohideen; D M McGarrell; A M Bandela; E Cardenas; G M Garrity; J M Tiedje Journal: Nucleic Acids Res Date: 2006-11-07 Impact factor: 16.971
Authors: Chao Zhao; Yijing Wu; Hai Yu; Ishita M Shah; Yanhong Li; Jie Zeng; Bin Liu; David A Mills; Xi Chen Journal: Chem Commun (Camb) Date: 2016-02-11 Impact factor: 6.222
Authors: Jennifer T Smilowitz; Carlito B Lebrilla; David A Mills; J Bruce German; Samara L Freeman Journal: Annu Rev Nutr Date: 2014-05-15 Impact factor: 11.848
Authors: Gaëlle Boudry; M Kristina Hamilton; Maciej Chichlowski; Saumya Wickramasinghe; Daniela Barile; Karen M Kalanetra; David A Mills; Helen E Raybould Journal: J Dairy Sci Date: 2017-01-26 Impact factor: 4.034